It is proposed to exclude patients with lesions ≥1 cm showing tumor uptake <0.5-fold of parotid uptake (or <1.0-fold liver uptake for 68Ga-PSMA-11) from 177Lu-PSMA-RLT (Figure 1). Here, FOLH1 is linked to neoplasm.